FDA staff blindsided by move allowing more e-cigarettes and nicotine pouches onto US market
Summary
The FDA recently issued new guidelines that allow some electronic cigarettes and nicotine pouches to be sold in the U.S. before full regulatory approval. This policy change surprised many FDA staff, who were not involved in the decision and only learned about it shortly before the announcement.Key Facts
- The FDA posted new vaping product guidelines online before the agency’s commissioner, Dr. Marty Makary, resigned.
- These guidelines let companies market certain nicotine products without full FDA review.
- Many FDA staff responsible for tobacco regulation were not consulted and found out about the policy last minute.
- The new guidelines skip the usual public comment period required for federal health policies.
- Internal FDA meetings are ongoing to figure out how to enforce the new rules.
- The change breaks from the FDA’s previous standard that required scientific proof of a product’s health benefits before approval.
- The policy shift came after complaints from industry lobbyists close to the White House.
- The Health and Human Services department said the approach aims to protect young people from nicotine addiction while helping adult smokers switch from cigarettes.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.